Previous
D.V.T AIRLINE RIDDLE SOLVEDD.V.T AIRLINE RIDDLE SOLVED
Added: (Fri Nov 30 2001)
MEDIA RELEASE
Product Systems Limited (PSL)of 64 Knightsbridge London SW1 X7JF has announced the release of a revolutionary new device to combat DVT on long haul aeroplane flights.
The research based company has developed a state of the art device to protect long haul air passengers from the potentially fatal effects of DVT.
“We are very proud of the high standards of innovation and technology that are coming out of Ireland at the moment” said Managing Director, Mr Gerard O’Connor.
“DVT is potentially fatal for airline passengers and can affect young and fit people – not just the elderly” said Hugh Cahill, Project Manager for PSL. “With the numbers of people travelling long distances by air, this device is long overdue”.
The potentially fatal effects of travel related DVT was highlighted by the unfortunate death of Emma Christoffersen, a 28 year old woman, on her return from a holiday in Australia.
It is conservatively estimated that there are over 131 million people who took a long haul flight during 2000. As many as 10% of these passengers could develop asymptomatic DVT, up to 260,000 people could develop symptomatic DVT and another 1,000 could die from the effects of DVT.
One of the causes of DVT is sitting immobile for long periods of time; a feature of long haul plane travel.
Veinguard is a world first in that it can monitor for immobility and warn passengers of the need to exercise their legs and feet. Veinguard will alert airline passengers to the need to perform exercise during air travel and monitor their exercise regime during the course of the flight.
John Cahill, who is in charge of technical development said that:
“In using the best technology in the world, we have a device that is compact, inexpensive and does not affect passenger comfort”.
Veinguard can save lives for less than the price of a good
cup of coffee.
Contact Hugh Cahill for further details on +44 77 4866 6662.
Printed out on 28 November 2001
To be distributed 30 November 2001
MEDIA RELEASE
Product Systems Limited (PSL)of 64 Knightsbridge London SW1 X7JF has announced the release of a revolutionary new device to combat DVT on long haul aeroplane flights.
The research based company has developed a state of the art device to protect long haul air passengers from the potentially fatal effects of DVT.
“We are very proud of the high standards of innovation and technology that are coming out of Ireland at the moment” said Managing Director, Mr Gerard O’Connor.
“DVT is potentially fatal for airline passengers and can affect young and fit people – not just the elderly” said Hugh Cahill, Project Manager for PSL. “With the numbers of people travelling long distances by air, this device is long overdue”.
The potentially fatal effects of travel related DVT was highlighted by the unfortunate death of Emma Christoffersen, a 28 year old woman, on her return from a holiday in Australia.
It is conservatively estimated that there are over 131 million people who took a long haul flight during 2000. As many as 10% of these passengers could develop asymptomatic DVT, up to 260,000 people could develop symptomatic DVT and another 1,000 could die from the effects of DVT.
One of the causes of DVT is sitting immobile for long periods of time; a feature of long haul plane travel.
Veinguard is a world first in that it can monitor for immobility and warn passengers of the need to exercise their legs and feet. Veinguard will alert airline passengers to the need to perform exercise during air travel and monitor their exercise regime during the course of the flight.
John Cahill, who is in charge of technical development said that:
“In using the best technology in the world, we have a device that is compact, inexpensive and does not affect passenger comfort”.
Veinguard can save lives for less than the price of a good
cup of coffee.
Contact Hugh Cahill for further details on +44 77 4866 6662.
Printed out on 28 November 2001
To be distributed 30 November 2001